Sonia Iyer

1.0k total citations
23 papers, 483 citations indexed

About

Sonia Iyer is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sonia Iyer has authored 23 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Sonia Iyer's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and PARP inhibition in cancer therapy (4 papers). Sonia Iyer is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and PARP inhibition in cancer therapy (4 papers). Sonia Iyer collaborates with scholars based in United States, South Korea and United Kingdom. Sonia Iyer's co-authors include William G. Kerr, Robert W. Brooks, Gwenny M. Fuhler, John D. Chisholm, Robert W. Engelman, Mi-Young Park, Michelle J. Smith, Matthew Gumbleton, Kim H.T. Paraiso and Sandra Fernandes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Sonia Iyer

21 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonia Iyer United States	12	282	155	121	65	43	23	483
Simone S. Riedel United States	14	262 0.9×	134 0.9×	81 0.7×	47 0.7×	34 0.8×	30	481
Praveena Thiagarajan United States	11	290 1.0×	143 0.9×	241 2.0×	112 1.7×	65 1.5×	17	597
Mallikarjuna Kandalam India	16	342 1.2×	119 0.8×	236 2.0×	88 1.4×	62 1.4×	27	592
Chelsea Bolyard United States	15	303 1.1×	286 1.8×	338 2.8×	80 1.2×	36 0.8×	24	782
Hong Seo Choi South Korea	12	272 1.0×	60 0.4×	86 0.7×	49 0.8×	48 1.1×	24	422
Giulia Chiaruttini United Kingdom	7	188 0.7×	203 1.3×	166 1.4×	68 1.0×	56 1.3×	10	446
Paula Boutin United States	11	216 0.8×	196 1.3×	120 1.0×	50 0.8×	36 0.8×	13	487
Nannan Kang China	9	187 0.7×	259 1.7×	106 0.9×	92 1.4×	9 0.2×	27	509
Michael H. Neale United Kingdom	15	514 1.8×	98 0.6×	371 3.1×	72 1.1×	76 1.8×	26	820
Hugues J. M. Nicolay Italy	10	637 2.3×	386 2.5×	289 2.4×	99 1.5×	31 0.7×	14	917

Countries citing papers authored by Sonia Iyer

Since Specialization

Citations

This map shows the geographic impact of Sonia Iyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Iyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Iyer more than expected).

Fields of papers citing papers by Sonia Iyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Iyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Iyer. The network helps show where Sonia Iyer may publish in the future.

Co-authorship network of co-authors of Sonia Iyer

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Iyer. A scholar is included among the top collaborators of Sonia Iyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Iyer. Sonia Iyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Westin, Shannon N., Kathleen N. Moore, Hye Sook Chon, et al.. (2025). Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation. International Journal of Gynecological Cancer. 35(2). 101703–101703.

Westin, Shannon N., Kathleen N. Moore, Michael S. Guy, et al.. (2025). Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for endometrial cancer: Longitudinal changes in circulating tumor DNA.. Journal of Clinical Oncology. 43(16_suppl). 5512–5512.

Reinmuth, Niels, Óscar Juan, Dariusz M. Kowalski, et al.. (2024). Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study. Clinical Cancer Research. 30(18). 4055–4067. 5 indexed citations

Westin, Shannon N., Kathleen N. Moore, Hye Sook Chon, et al.. (2024). LB002/#1594 Durvalumab plus carboplatin/paclitaxel followed by durvalumab with/without olaparib in endometrial cancer: exploratory analyses of biomarker/histological heterogeneity and efficacy in the DUO-E mismatch repair proficient subpopulation. Lirias (KU Leuven). A4–A5. 3 indexed citations

Chauvin, Maëva, Marie-Charlotte Meinsohn, Santosh K. Dasari, et al.. (2023). Cancer-associated mesothelial cells are regulated by the anti-Müllerian hormone axis. Cell Reports. 42(7). 112730–112730. 11 indexed citations

Iyer, Sonia, James Conway, Deanna L. Russell, et al.. (2023). Abstract CT039: Immunomodulatory effects of ceralasertib in combination with durvalumab in patients with NSCLC and progression on anti-PD-(L)1 treatment (HUDSON, NCT03334617). Cancer Research. 83(8_Supplement). CT039–CT039. 2 indexed citations

Zhou, Yunlan, Erica Perry, Sonia Iyer, et al.. (2023). Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer. Cell Reports. 42(10). 113144–113144. 5 indexed citations

Jo, Ala, Jamie E. Medina, Sonia Iyer, et al.. (2023). Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection (Adv. Sci. 27/2023). Advanced Science. 10(27). 2 indexed citations

Jo, Ala, Jamie E. Medina, Sonia Iyer, et al.. (2023). Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection. Advanced Science. 10(27). e2301930–e2301930. 23 indexed citations

10.

Cheema, Parneet, Sylvia Hartl, Marianna Koczywas, et al.. (2023). 695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON). SHILAP Revista de lepidopterología. A787–A787. 5 indexed citations

11.

Smith, Sean G., Ivan S. Pires, Sonia Iyer, et al.. (2022). Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors. Bioengineering & Translational Medicine. 8(2). e10453–e10453. 25 indexed citations

12.

Machado, Susana, et al.. (2022). LACTB exerts tumor suppressor properties in epithelial ovarian cancer through regulation of Slug. Life Science Alliance. 6(1). e202201510–e202201510. 7 indexed citations

13.

Iyer, Sonia, Hao Ran, Igor Dolgalev, et al.. (2020). Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. Cancer Discovery. 11(2). 362–383. 61 indexed citations

14.

Srivastava, Neetu, Sonia Iyer, Raki Sudan, et al.. (2016). A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome. JCI Insight. 1(11). 26 indexed citations

15.

Iyer, Sonia, Hajime Akada, Sudha Neelam, et al.. (2015). Coordinate Expansion of Murine Hematopoietic and Mesenchymal Stem Cell Compartments by SHIPi. Stem Cells. 33(3). 848–858. 21 indexed citations

16.

Iyer, Sonia, et al.. (2014). SHIP1 Regulates MSC Numbers and Their Osteolineage Commitment by Limiting Induction of the PI3K/Akt/β-Catenin/Id2 Axis. Stem Cells and Development. 23(19). 2336–2351. 18 indexed citations

17.

Iyer, Sonia, Robert W. Brooks, Matthew Gumbleton, & William G. Kerr. (2014). SHIP1-Expressing Mesenchymal Stem Cells Regulate Hematopoietic Stem Cell Homeostasis and Lineage Commitment During Aging. Stem Cells and Development. 24(9). 1073–1081. 16 indexed citations

18.

Fernandes, Sandra, Sonia Iyer, & William G. Kerr. (2013). Role of SHIP1 in cancer and mucosal inflammation. Annals of the New York Academy of Sciences. 1280(1). 6–10. 33 indexed citations

19.

Fuhler, Gwenny M., Robert W. Brooks, Bonnie B. Toms, et al.. (2011). Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer. Molecular Medicine. 18(1). 65–75. 91 indexed citations

20.

Brooks, Robert W., Gwenny M. Fuhler, Sonia Iyer, et al.. (2010). SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells. The Journal of Immunology. 184(7). 3582–3589. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact